Question follow-through · 111501
Wheelchairs: Health Services
To ask the Secretary of State for Health and Social Care, what statistics he has on the demand for and use of wheelchairs; and how that data informs NHS England’s commissioning of appropriate services.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 6 Feb 2026
- Target answer date
- 10 Feb 2026
- Answer
- 17 Feb 2026 · 11 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Cancer: Screening · 10 Feb 2026
- Rare Cancers: Health Services · 10 Feb 2026
- Cancer: Drugs · 10 Feb 2026
- Rare Cancers: Health Services · 10 Feb 2026
- Radiotherapy: Medical Equipment · 20 Feb 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
6 Feb 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what statistics he has on the demand for and use of wheelchairs; and how that data informs NHS England’s commissioning of appropriate services.
10 Feb 2026
Target answer date
Date supplied by the official written-questions record.
17 Feb 2026
Answer published
Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchair services, based on the needs of their local population. NHS England supports ICBs to commission effective, efficient, and personalised wheelchair service...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Cancer: Screening
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the expansion of diagnostic genomic testing for cancer is accompanied by timely NHS access to targeted therapies identified by that testing, including where s
Rare Cancers: Health Services
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, what provision the National Cancer Plan will make for orphan drug pathways for patients with rare cancers requiring personalised treatment plans; and how those pathways will differ from existing co
Cancer: Drugs
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to align NICE appraisal timelines, MHRA regulatory pathways and NHS commissioning decisions to support the delivery of personalised cancer medicines.
Rare Cancers: Health Services
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, with reference to page 75 of the policy paper entitled A National Cancer Plan for England: delivering world class cancer care, whether it is his policy that patients with rare cancers should be off
Radiotherapy: Medical Equipment
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, how much of the £70 million allocated in the Autumn Budget 2024 for new linear accelerator (LINAC) machines has been spent to date; how many new LINAC machines have been procured with that funding;
National Cancer Board
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, with reference to Action 21 of the National Cancer Plan, when his Department expects the reformed National Cancer Board to be established.
National Cancer Board
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, with reference to Action 21 of the National Cancer Plan, what appointment process will be used to select the independent representative who will co chair the reformed National Cancer Board.
Rare Cancers: Medical Treatments
25 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to help support access to genomically-matched targeted therapies for patients with rare cancers, where genomic testing identifies a suitable option but large-scale clinical
Rare Cancers: Medical Treatments
25 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether specialist multidisciplinary teams and designated centres of excellence will be given clear guidance and authority to prescribe off-label treatments supported by genomic evidence and aligne
Rare Cancers: Medical Treatments
25 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether the joint accelerated approvals pathway operated by the National Institute for Health and Care Excellence and Medicines and Healthcare products Regulatory Agency will enable tumour-agnostic
Vitamin D: Deficiency Diseases
25 Feb 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 February 2026 to Question 110574 on Vitamin D: Deficiency Diseases, what his planned timeline is for the rapid review by the Scientific Advisory Committee on Nutrition
Vitamin D: Deficiency Diseases
25 Feb 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 February 2026 to Question 110574 on Vitamin D: Deficiency Diseases, whether the rapid review by the Scientific Advisory Committee on Nutrition will assess optimal vitam